Delivery Order SPE2DB22D3501-SPE2DB25FXE12
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $13,483.53 to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Lupron Depot 11.25 mg 3-month kits, with completion targeted for September 15, 2025. This competitively awarded, firm fixed-price delivery order is being performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical procurement supporting military and federal healthcare systems through...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of Lupron Depot 11.25 mg 3-month kits, valued at $3,344.81. This delivery order is issued under a firm fixed-price contract type with no set-aside designation, indicating competitive award. The product will be delivered to the contractor's location in Conshohocken, Pennsylvania, with an ultimate completion date of September 8, 2025. This delivery order represents a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 20, 2025, for the supply of Lupron Depot 11.25 mg 3-month kits valued at $10,499.78. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under open competition. The order is scheduled for ultimate completion by June 23, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a major pharmaceutical...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $8,201.87 for Lupron Depot 11.25 mg 3-month kits, with an ultimate completion date of September 4, 2025. This is a firm fixed price delivery order under a non-set-aside competitive procurement. The contractor, headquartered in Conshohocken, Pennsylvania, will perform work at its corporate office location. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $17,759.51 to AmerisourceBergen Drug Corp for the supply of Lupron Depot 11.25 mg 3-month kits. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded with a completion date of September 9, 2025. The award was made to AmerisourceBergen's corporate office, with performance to be executed at the company's facility in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency's Medical Supply Chain has awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Lupron Depot 11.25 mg 3-month treatment kits under a firm fixed-price contract. The award, valued at $47,687.90 and dated April 23, 2025, represents a single delivery order with an ultimate completion date of April 24, 2025. This contract was competitively awarded with no set-aside designation, and performance will be executed from the contractor's corporate office...
- The Defense Logistics Agency awarded a delivery order valued at $29,366.00 to AmerisourceBergen Drug Corp for Lupron Depot 11.25 mg three-month kits under a firm fixed-price contract. The award was made on November 13, 2025, with an ultimate completion date of November 14, 2025. This delivery order is issued without a set-aside designation, reflecting open competition. AmerisourceBergen will fulfill this order from its facility in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $14,027.19 to AmerisourceBergen Drug Corp for the supply of Lupron Depot 11.25 mg 3-month kits. The contract is a firm fixed price delivery order with an ultimate completion date of November 3, 2025, and was awarded on October 31, 2025. This award carries no set-aside designation, indicating it was competitively awarded. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work from its...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for Lupron Depot 11.25 mg 3-month kits valued at $7,855.98 under a firm fixed-price contract. This non-set-aside delivery order is scheduled for completion by August 11, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical procurement through the company's existing...
- The Defense Logistics Agency awarded a delivery order valued at $8,203.82 to AmerisourceBergen Drug Corp for the supply of Lupron Depot 11.25 mg 3-month kits. The contract carries firm fixed price terms with no set-aside designation and is scheduled for completion by August 25, 2025. Performance will occur at the contractor's facility in Conshohocken, Pennsylvania. This delivery order represents a competitive procurement under the pharmaceutical supply chain managed by DLA Troop Support Medical....
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB25FXE12Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Lupron Depot 11.25 mg 3-month kits on September 4, 2025, with a ceiling value of $11,202.07. This firm fixed price, non-set-aside delivery order is scheduled for ultimate completion on September 5, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award represents a continuation of the contractor's significant role in supporting federal medical procurement, particularly for military and veteran healthcare systems. This delivery order operates under AmerisourceBergen Drug Corp's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a wide range of medications, medical devices, and healthcare commodities to support military healthcare programs worldwide. AmerisourceBergen's demonstrated capability to compete successfully for federal medical supply contracts, combined with its extensive portfolio of pharmaceutical deliveries across multiple therapeutic domains, positions it as a critical vendor for the Defense Logistics Agency's medical supply chain operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.2k | 9/4/25 |